News | July 03, 2012

Abbreviated ECHO/ECG Protocol Might Protect Young Athletes

July 3, 2012 — While rare, when sudden cardiac death occurs in a seemingly healthy competitive young athlete, the societal loss is high. At a time when the world is battling obesity in epidemic proportions, fear should not affect how parents view athletic participation. A recent study, to be presented at the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions, June 27 to July 3, 2012, at the Gaylord National in National Harbor, Md., suggests an abbreviated echocardiographic profile may potentially help identify young athletes at risk for sudden cardiac death and to help athletes, their physicians and families make better decisions about full participation in athletic activities. A poster based on the study was displayed July 1. 

“The primary causes of sudden cardiac death are anatomic anomalies, and abnormalities of the muscular and electrical systems. Present athletic screening involves the taking of a thorough personal and family history, physical examination, and, if indicated, further cardiac testing. While ideal, the addition of EKG and echocardiography to every screening examination is extremely time-consuming and is currently cost-prohibitive. In our study, we designed a protocol which allows a less costly, abbreviated echocardiogram as well as EKG in a mass screening scenario. The goal is to provide more a more complete data set which is cost-effective to care providers, who may then better counsel athletes and their families on full participation in sports. While the cost-effectiveness and impact on the rate reduction of sudden cardiac death are not yet known, the impact on quality of life in reassurance of cardiac health during exercise is priceless,” said Michelle A. Grenier, lead investigator on the study. Robert Hinton, Timothy J. Knilans, John L. Jefferies, Wayne Mays, Nicholas Edwards, Jeffrey Towbin, Richard Czosek, and Jeffery Anderson, all of Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio, were also part of the research team.

The study found that the number of patients with clinically silent aortopathy and myocardial abnormalities appears disproportionately high in these active athletic adolescents. The abbreviated echo format allows for rapid screening of athletes as part of a general sports screening. The impact of early identification and intervention strategies, as well as screening of at risk, first-degree relatives, is not known, but suggests the utility of echo in detecting aortic and myocardial pathology. The risk of these abnormalities having gone undetected is not known. 
 


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now